AI Article Synopsis

  • The research focuses on developing new compounds based on existing antiplatelet and anti-inflammatory agents, specifically looking at 2,4-diamino-benzopyranopyrimidines and 2-amino-5,6-dihydrobenzo[h]quinazolines.
  • New 5,6-dihydrobenzo[h]quinazoline compounds were synthesized with amino groups added at the 2 and 4 positions, enhancing their medicinal properties.
  • The resulting compounds showed strong antiplatelet activity similar to aspirin and anti-inflammatory effects comparable to indomethacin, a standard reference drug.

Article Abstract

In pursuing our research on some 2,4-diamino-benzopyranopyrimidines and 2-amino-5,6-dihydrobenzo[h]quinazolines, previously reported as antiplatelet and analgesic/anti-inflammatory agents respectively, we designed and synthesized a new series of 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted. The insertion of amino substituents at positions 2 and 4 of the benzoquinazoline scaffold resulted in compounds endowed with a potent ASA-like antiplatelet activity, combined with an anti-inflammatory activity comparable, in some cases, to that of indomethacin, used as a reference drug.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2011.11.103DOI Listing

Publication Analysis

Top Keywords

56-dihydrobenzo[h]quinazoline 24-diamino
8
24-diamino substituted
8
synthesis 56-dihydrobenzo[h]quinazoline
4
substituted antiplatelet/antiphlogistic
4
antiplatelet/antiphlogistic activities
4
activities evaluation
4
evaluation pursuing
4
pursuing 24-diamino-benzopyranopyrimidines
4
24-diamino-benzopyranopyrimidines 2-amino-56-dihydrobenzo[h]quinazolines
4
2-amino-56-dihydrobenzo[h]quinazolines reported
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!